Back

The Pediatric Obesity Microbiome and Metabolism Study (POMMS): Methods, Baseline Data, and Early Insights.

McCann, J. R.; Bihlmeyer, N. A.; Roche, K.; Catherine, C.; Jawahar, J.; Kwee, L. C.; Younge, N. E.; Silverman, J.; Ilkayeva, O.; Sarria, C. J.; Zizzi, A.; Wootton, J.; Poppe, L.; Anderson, P. R.; Arlotto, M.; Wei, Z.; Granek, J. A.; Valdivia, R. H.; David, L. F.; Dressman, H. K.; Newgard, C. B.; Shah, S. H.; Seed, P. C.; Rawls, J. F.; Armstrong, S. C.

2020-06-11 pediatrics
10.1101/2020.06.09.20126763
Show abstract

ObjectiveTo establish a biorepository of clinical, metabolomic, and microbiome samples from adolescents with obesity as they undergo lifestyle modification. MethodsWe enrolled 223 adolescents aged 10-18 years with Body Mass Index [≥] 95th percentile, along with 71 healthy weight participants. We collected clinical data, fasting serum, and fecal samples at repeated intervals over 6 months. Here we present our study design, data collection methods, and an interim analysis, including targeted serum metabolite measurements and fecal 16S rRNA gene amplicon sequencing among adolescents with obesity (n=27) and healthy weight controls (n=27). ResultsAdolescents with obesity have higher serum alanine aminotransferase, C-reactive protein, and glycated hemoglobin, and lower high-density lipoprotein cholesterol when compared with healthy weight controls. Metabolomics revealed differences in branched chain amino acid related metabolites. We also observed differential abundance of specific microbial taxa and lower species diversity among adolescents with obesity when compared with the healthy weight group. ConclusionsThe Duke Pediatric Metabolism and Microbiome Study biorepository is available as a shared resource. Early findings suggest evidence of a metabolic signature of obesity unique to adolescents, along with confirmation of previously reported findings describing metabolic and microbiome markers of obesity. Clinical Trial RegistrationBiorepository: NCT02959034 Observational Trial: NCT03139877 What is already known about this subject?O_LIThe intestinal microbiome plays an important role in adult obesity and regulation of metabolism. Although it is well-established that obesity has its roots in childhood, very little is known about the role of the microbiome in pediatric obesity and how it changes during adolescence. C_LI What are the new findings in your manuscript?O_LIThis manuscript provides details of a new shared biorepository including clinical data, stool samples and plasma samples from a diverse cohort of 223 adolescents with obesity followed longitudinally over 6 months during a weight management intervention, as well as 71 adolescents with healthy weight as a comparison group. C_LIO_LIInterim analyses suggest that adolescents with obesity have microbiome signatures and metabolite profiles similar to adults, however key differences in microbial communities and metabolic by-products are identified. C_LI How might your results change the direction of research or focus of clinical practice?O_LIThe POMMS biorepository will be available for investigators to use in future research, to elucidate the underlying mechanisms of obesity and related chronic health conditions. C_LIO_LIPreliminary data reveal metabolite profiles that suggest adolescence may be a window of metabolic plasticity and disease reversibility C_LIO_LIMicrobiome and metabolomic signatures suggest potential biomarkers that may serve as prognostic or predictive factors in disease remission, or targets for future therapeutics. C_LI

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
International Journal of Obesity
based on 17 papers
Top 0.1%
16.7%
2
Gut Microbes
based on 15 papers
Top 0.1%
12.1%
3
Obesity
based on 11 papers
Top 0.1%
12.1%
4
Cell Reports Medicine
based on 49 papers
Top 0.3%
5.8%
5
JCI Insight
based on 63 papers
Top 2%
3.2%
6
Pediatric Research
based on 15 papers
Top 0.6%
3.2%
50% of probability mass above
7
Nature Communications
based on 483 papers
Top 20%
3.0%
8
Nutrients
based on 43 papers
Top 2%
2.6%
9
BMJ Open
based on 553 papers
Top 32%
2.6%
10
The Journal of Pediatrics
based on 15 papers
Top 0.8%
2.5%
11
eBioMedicine
based on 82 papers
Top 1%
2.4%
12
Scientific Reports
based on 701 papers
Top 67%
1.9%
13
Clinical and Translational Science
based on 14 papers
Top 0.8%
1.7%
14
The Journal of Clinical Endocrinology & Metabolism
based on 26 papers
Top 2%
1.7%
15
PLOS ONE
based on 1737 papers
Top 92%
1.3%
16
mBio
based on 34 papers
Top 3%
0.9%
17
Journal of the American Heart Association
based on 92 papers
Top 10%
0.9%
18
Translational Psychiatry
based on 94 papers
Top 7%
0.9%
19
PLOS Medicine
based on 95 papers
Top 13%
0.9%
20
JAMA Network Open
based on 125 papers
Top 16%
0.9%
21
Frontiers in Endocrinology
based on 20 papers
Top 3%
0.7%
22
Clinical Infectious Diseases
based on 219 papers
Top 21%
0.7%
23
Cell Genomics
based on 34 papers
Top 4%
0.7%
24
Nature Medicine
based on 88 papers
Top 17%
0.7%
25
Frontiers in Pediatrics
based on 24 papers
Top 3%
0.7%
26
Diabetologia
based on 23 papers
Top 2%
0.7%